Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

CNS 2Breast 2

Conditions

Breast Neoplasms 4Brain Neoplasms 2Triple Negative Breast Neoplasms 1Neoplasm Metastasis 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Surveys and Questionnaires 15Radiosurgery 14Magnetic Resonance Imaging 11Magnetic Resonance Spectroscopy 10Neuropsychological Tests 8Radiotherapy 7Radiation 4Blood Specimen Collection 4Patient Reported Outcome Measures 3sacituzumab govitecan 2Trastuzumab 2Surgical Procedures, Operative 2Quality of Life 2Physical Examination 2Phlebotomy 2Perfusion Magnetic Resonance Imaging 2Lead 2Lapatinib 2Interviews as Topic 2Immunotherapy 2Drug Therapy 2Data Collection 2Brain Mapping 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 2Aminolevulinic Acid 2trastuzumab deruxtecan 1pembrolizumab 1osimertinib 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Brain Neoplasms × sacituzumab govitecan × Clear all
NCT07251868 2025-11-26

Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study

Peking University Cancer Hospital & Institute

Recruiting
100 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT06504719 2025-09-15

Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan

Hellenic Cooperative Oncology Group

Completed
312 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡